Milrinone
It is a phosphodiesterase 3 inhibitor that works to increase the heart’s contractility and decrease pulmonary vascular resistance. Milrinone also works to vasodilate which helps alleviate increased pressures (afterload) on the heart, thus improving its pumping action.
Indications:
Short term management of CCF in patient unresponsive to digitalis, diuretics or vasodilators etc.
Side Effects:
Headache, Hyperkalemia, tremors, ventricular arrhythmias, hypotension etc.
Dosage Forms:
Milrinone 10 mg/10 ml injections
Combinations:
Brand Names (Company Name)
Milicor (Samarth Pharma Pvt. Ltd.)
Milrineon (Neon Laboratories Ltd)
Mirisol (Shree Ganesh Rubber & Chemicals Co)
Myolong (VHB Life Sciences Limited)
Primacor (Sanofi Aventis)
Leave a Reply